7 Facts to know from the first human experience with an endoscopic duodenal-jejunal bypass sleeve

The world of medical advancements is nothing short of awe-inspiring, with breakthroughs that push the boundaries of what’s possible. One such innovation is the endoscopic duodenal-jejunal bypass sleeve (DJBS). This novel, minimally invasive device offers solutions for managing obesity. But what do we know about the first human experience with this groundbreaking procedure? Let’s take a closer look at some fascinating facts from this study through the eyes of Dr. Alexander Shapsis of EndoSlim Clinic at Atlantic Gastroenterology of Brooklyn, New York.

Seven facts about the human study of DJBS use

1. Minimally invasive but highly effective. The endoscopic duodenal-jejunal bypass sleeve is placed non-surgically via an endoscope, eliminating the need for major surgeries. This means shorter recovery times and reduced risks compared to traditional bariatric surgeries. It’s a win-win solution for our patients looking for less invasive treatment options.
2. Reversible and adjustable. Unlike surgical procedures, the DJBS is temporary and fully reversible. It’s typically implanted for about a year, giving patients an adaptable tool to support their weight loss and health journeys. It offers a layer of flexibility that traditional methods lack.
3. Initial trials showed promising results. The first human trials of the DJBS revealed remarkable results. Patients experienced significant weight loss while also showing improvement in glycemic control. These outcomes sparked excitement among researchers for the potential widespread use of the device.
4. It targets the root of the problem. The device works by blocking food from entering the first part of the small intestine (the duodenum). This alteration influences how the body processes nutrients and hormones, creating metabolic improvements beyond simple calorie restriction.
5. Designed with patient safety in mind. Safety and comfort were top priorities in the DJBS’s design. Side effects such as gastrointestinal discomfort were mild and manageable during the initial trials. This reassures future patients that the procedure is effective and safe.
6. The endoscopic technique for placement and removal is a game-changer. Using an endoscope to place the device means patients avoid the risks of general anesthesia and extensive incisions. This innovation represents an important step forward in making effective obesity treatments more accessible and less intrusive.
7. Support beyond the device. The success observed during the DJBS trials wasn’t just about the technology. It also means that comprehensive support from medical teams was a key factor. Personalized follow-ups and nutritional counseling enhanced long-term results and improved patient experiences.

Learn more with an appointment at Atlantic Gastroenterology!

Are you curious about how modern gastrointestinal innovations like the duodenal-jejunal bypass sleeve can revolutionize your overall health by helping you battle obesity? Visit EndoSlim Clinic at Atlantic Gastroenterology of Brooklyn, NY, and connect with Dr. Alexander Shapsis and his dedicated team of experts. Call 718 521-2840 to make your appointment. They are located on Ocean Parkway, Bay Pkwy, and Court Street, Brooklyn. They also have a clinic at 12462 W Atlantic Blvd, Coral Springs, FL, 33071. The team is ready to guide you toward better health with cutting-edge solutions and compassionate care. 

Share this Article